M&A MVP: Kirkland & Ellis' Daniel Wolf
Kirkland & Ellis LLP partner Daniel Wolf's lead in some of 2012's most complicated, high-profile deals — including Bristol-Myers Squibb Co.'s $7 billion acquisition and subsequent share partitioning of Amylin Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article